Sample of control arm data for package examples from a phase 3, randomized, open-label study evaluating DN-101 in combination with Docetaxel in androgen-independent prostate cancer (AIPC) (ASCENT-2). The data was obtained from Project Data Sphere (sponsor Novacea, Inc).
Usage
data("sampleData")
Arguments
Format
A data frame with 1250 observations on the following 3 variables.